Lyell Immunopharma, Inc.(LYEL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LYEL Lyell Immunopharma, Inc.

已收盘 06-12 16:00:00 EDT

13.50

-0.22

-1.60%

盘后13.50

+0.000.00%

16:10 EDT

最高13.80	最低13.08	成交量9.99万
今开13.67	昨收13.72	日振幅5.25%
总市值3.15亿	流通市值1.91亿	总股本2,331万
成交额134.46万	换手率0.71%	流通股本1,416万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LYEL","market":"US","secType":"STK","nameCN":"Lyell Immunopharma, Inc.","latestPrice":13.5,"timestamp":1781294400000,"preClose":13.72,"halted":0,"volume":99935,"hourTrading":{"tag":"盘后","latestPrice":13.5,"preClose":13.5,"latestTime":"16:10 EDT","volume":3508,"amount":47358,"timestamp":1781295004974,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01603498542274057,"floatShares":14162100,"shares":23307143,"eps":-13.055832,"marketStatus":"已收盘","change":-0.22,"latestTime":"06-12 16:00:00 EDT","open":13.67,"high":13.8,"low":13.08,"amount":1344641,"amplitude":0.052478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-13.055832,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1781510400000},"marketStatusCode":5,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":13.72,"preHourTrading":{"tag":"盘前","latestPrice":14.19,"preClose":13.72,"latestTime":"05:48 EDT","volume":19,"amount":268.75919899999997,"timestamp":1781257682779,"change":0.47,"changeRate":0.034257,"amplitude":0.005168},"postHourTrading":{"tag":"盘后","latestPrice":13.5,"preClose":13.5,"latestTime":"16:10 EDT","volume":3508,"amount":47358,"timestamp":1781295004974,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.819805,"impliedVol":0.7849,"impliedVolPercentile":0.7092},"requestUrl":"/m/hq/s/LYEL/tweets","defaultTab":"tweets","newsList":[{"id":"1120866776","title":"Lyell Immunopharma公布Ronde-Cel临床数据：治疗超百例2L及3L+LBCL患者，制造成功率高达97%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120866776","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120866776?lang=zh_cn&edition=full","pubTime":"2026-06-13 00:49","pubTimestamp":1781282986,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma公司宣布，其候选疗法Ronde-Cel在针对二线及三线或以上大B细胞淋巴瘤患者的临床中，已成功治疗超过100名患者。数据显示，该疗法的制造成功率达到了97%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","LYEL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160177579","title":"Lyell Immunopharma在欧洲血液学协会2026年大会上公布Rondecabtagene Autoleucel（Ronde-Cel）治疗大B细胞淋巴瘤患者的最新安全数据与转化洞见","url":"https://stock-news.laohu8.com/highlight/detail?id=1160177579","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160177579?lang=zh_cn&edition=full","pubTime":"2026-06-13 00:48","pubTimestamp":1781282896,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma在欧洲血液学协会2026年大会上，公布了其候选疗法Rondecabtagene Autoleucel（Ronde-Cel）用于大B细胞淋巴瘤患者的最新安全数据与转化研究成果。此次披露的信息为这一细胞疗法的临床进展提供了关键更新。\n该公司展示的数据聚焦于疗法的安全性特征以及从实验室到临床的深入洞见。这些发现有助于进一步评估Ronde-Cel在应对这一侵袭性淋巴瘤方面的潜力与风险平衡。\n大会上的报告为医学界提供了关于该疗法最新进展的重要参考。相关数据的公布是Lyell Immunopharma推进其研发管线过程中的一个环节。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4505","LYEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100269218","title":"Lyell Immunopharma：Pivotal试验数据更新预计2026年下半年公布，BLA提交计划于2027年下半年进行","url":"https://stock-news.laohu8.com/highlight/detail?id=1100269218","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100269218?lang=zh_cn&edition=full","pubTime":"2026-06-13 00:48","pubTimestamp":1781282893,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma公司宣布，其关键性临床试验的数据更新预计将在2026年下半年获得。此外，公司计划于2027年下半年提交生物制品许可申请（BLA）。这一时间表标志着该公司在推进其研发管线方面的重要节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4505","BK4139","LYEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135624151","title":"Lyell Immunopharma更新Lyl273在复发或难治性转移性结直肠癌中的安全性数据，并将一期试验扩展为一/二期","url":"https://stock-news.laohu8.com/highlight/detail?id=1135624151","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135624151?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:02","pubTimestamp":1780912947,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma公司宣布，已就其候选药物Lyl273在治疗复发或难治性转移性结直肠癌患者中的安全性概况提供了最新信息。同时，公司决定将原计划的一期临床试验方案修订并扩展为一/二期试验。此举旨在进一步评估该疗法的安全性与初步疗效，为后续的临床开发路径收集更全面的数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL","BK4505","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148869180","title":"Lyell Immunopharma任命Smital Shah为首席财务与商务官兼主要财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1148869180","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148869180?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:09","pubTimestamp":1773058151,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma, Inc.宣布任命Smital Shah担任首席财务与商务官及主要财务官职务。这一重要人事变动将进一步加强公司在财务战略与商业运营方面的领导力，为未来发展注入新的动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4505","LYEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115827606","title":"Lyell Immunopharma完成额外5000万美元股权私募融资并任命Smital Shah为首席财务与业务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1115827606","media":"美股速递","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115827606?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:02","pubTimestamp":1773057765,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma, Inc.（以下简称“Lyell Immunopharma”）近日宣布，公司已完成额外5000万美元的股权私募融资。与此同时，公司正式任命Smital Shah担任首席财务与业务官一职，负责统筹公司的财务与业务发展策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYEL","BK4139","BK4505","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106628289","title":"Lyell Immunopharma启动首例头对头CAR-T细胞疗法3期临床试验，针对侵袭性大B细胞淋巴瘤患者开始给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1106628289","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106628289?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:31","pubTimestamp":1770899474,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma, Inc.（简称Lyell）宣布，在一项开创性的3期临床试验中，已开始对侵袭性大B细胞淋巴瘤患者进行给药。该试验采用头对头比较设计，是同类CAR-T细胞疗法中的首例研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4539","LYEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610959478","title":"Lyell Immunopharma, Inc.盘中异动 早盘大幅下跌5.19%报22.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610959478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610959478?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:58","pubTimestamp":1770821896,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日22时58分，Lyell Immunopharma, Inc.股票出现异动，股价大幅跳水5.19%。截至发稿，该股报22.48美元/股，成交量6036股，换手率0.03%，振幅3.23%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。其相关个股中，Quince Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Phio Pharmaceuticals Corp.涨幅较大，Pmgc Holdings Inc.、Quince Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1964.18%、322.57%、180.28%，振幅较大的相关个股有Quince Therapeutics, Inc.、Tuhura Biosciences, Inc.、Biorestorative Therapies, Inc.，振幅分别为27.25%、23.08%、21.76%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122581797a5d337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122581797a5d337&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LYEL","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595723519","title":"Lyell Immunopharma, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595723519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595723519?lang=zh_cn&edition=full","pubTime":"2025-12-30 23:20","pubTimestamp":1767108023,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日23时20分，Lyell Immunopharma, Inc.股票出现波动，股价快速下跌5.13%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Dermata Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Dermata Therapeutics, Inc.、Gri Bio, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为1745.05%、611.82%、38.17%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为37.47%、37.42%、30.29%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232023a48ae223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232023a48ae223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4505","LYEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518276241","title":"Lyell Immunopharma, Inc.盘中异动 股价大跌5.50%报0.702美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276241?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:08","pubTimestamp":1741615693,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时08分，Lyell Immunopharma, Inc.股票出现波动，股价急速下跌5.50%。截至发稿，该股报0.702美元/股，成交量1.5766万股，换手率0.01%，振幅2.49%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3198.22%、693.41%、99.01%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Impact Biomedical, Inc.，振幅分别为40.24%、32.14%、28.59%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022081396403f35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022081396403f35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4539","LYEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517600808","title":"Lyell Immunopharma, Inc.盘中异动 下午盘快速拉升5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517600808?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:39","pubTimestamp":1741113562,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时39分，Lyell Immunopharma, Inc.股票出现波动，股价大幅拉升5.82%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Immatics N V C/Wts 01/07/2025 、Protagenic Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1287.72%、1183.09%、1142.85%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为122.48%、66.67%、66.02%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305023923989be6d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305023923989be6d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYEL","BK4539","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634275","title":"Lyell Immunopharma, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634275?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012319,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Lyell Immunopharma, Inc.股票出现异动，股价急速下挫5.04%。截至发稿，该股报0.675美元/股，成交量1.0313万股，换手率0.00%，振幅2.81%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.20%、24.20%、22.45%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为15.16%、9.55%、9.35%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223200abe63343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223200abe63343&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LYEL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514686899","title":"Lyell Immunopharma, Inc.盘中异动 大幅拉升5.05%报0.691美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514686899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514686899?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:47","pubTimestamp":1740588477,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时47分，Lyell Immunopharma, Inc.股票出现异动，股价快速上涨5.05%。截至发稿，该股报0.691美元/股，成交量18.9972万股，换手率0.07%，振幅3.88%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Madrigal Pharmaceuticals, Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5962.62%、216.63%、216.40%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Organovo Holdings, Inc.，振幅分别为181.36%、49.18%、43.31%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022700475796316916&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022700475796316916&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYEL","BK4539","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514501802","title":"Lyell Immunopharma, Inc.盘中异动 早盘急速上涨8.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514501802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514501802?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493877,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Lyell Immunopharma, Inc.股票出现异动，股价大幅拉升8.10%。截至发稿，该股报0.719美元/股，成交量5617股，换手率0.00%，振幅0.00%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为747.41%、521.43%、460.59%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Maze Therapeutics, Inc.，振幅分别为32.52%、16.59%、8.87%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223117a2538666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223117a2538666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LYEL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514775498","title":"Lyell Immunopharma, Inc.盘中异动 股价大涨5.47%报0.739美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775498?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:15","pubTimestamp":1740413705,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时15分，Lyell Immunopharma, Inc.股票出现波动，股价快速拉升5.47%。截至发稿，该股报0.739美元/股，成交量74.1012万股，换手率0.27%，振幅7.64%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Pepgen Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为242.25%、108.26%、33.17%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为162.04%、55.69%、53.34%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225001506a2522ca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225001506a2522ca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYEL","BK4139","BK4539","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513329665","title":"Lyell Immunopharma, Inc.盘中异动 股价大涨5.12%报0.694美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513329665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513329665?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:36","pubTimestamp":1740148597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时36分，Lyell Immunopharma, Inc.股票出现波动，股价大幅上涨5.12%。截至发稿，该股报0.694美元/股，成交量7.0176万股，换手率0.03%，振幅3.06%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223638a24eb1aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223638a24eb1aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYEL","BK4505","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512712166","title":"Lyell Immunopharma, Inc.盘中异动 早盘快速跳水6.29%报0.572美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512712166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512712166?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:02","pubTimestamp":1739890937,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时02分，Lyell Immunopharma, Inc.股票出现异动，股价快速跳水6.29%。截至发稿，该股报0.572美元/股，成交量14.2164万股，换手率0.05%，振幅4.77%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为330.26%、126.20%、116.52%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.，振幅分别为41.79%、34.04%、31.62%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230217a24ab3a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230217a24ab3a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4539","LYEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511729875","title":"Lyell Immunopharma, Inc.盘中异动 临近收盘股价大涨5.12%报0.564美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511729875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511729875?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:30","pubTimestamp":1739478652,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时30分，Lyell Immunopharma, Inc.股票出现异动，股价大幅上涨5.12%。截至发稿，该股报0.564美元/股，成交量42.0482万股，换手率0.15%，振幅5.22%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3258.43%、2261.67%、1261.87%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214043052a244f178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214043052a244f178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYEL","BK4539","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510332694","title":"Lyell Immunopharma, Inc.盘中异动 股价大跌5.06%报0.526美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510332694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510332694?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:06","pubTimestamp":1739293616,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时06分，Lyell Immunopharma, Inc.股票出现异动，股价急速下挫5.06%。截至发稿，该股报0.526美元/股，成交量32.4172万股，换手率0.12%，振幅5.75%。Lyell Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.76%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Oramed Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3015.34%、1344.64%、440.27%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.46%、58.60%。Lyell Immunopharma, Inc.公司简介：Lyell Immunopharma Inc 是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212010656a2421c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212010656a2421c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4539","LYEL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lyell.com","stockEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.2873},{"period":"3month","weight":-0.3544},{"period":"6month","weight":-0.6019},{"period":"1year","weight":0.458},{"period":"ytd","weight":-0.5543}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.114},{"period":"6month","weight":0.0821},{"period":"1year","weight":0.2268},{"period":"ytd","weight":0.0819}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lyell Immunopharma, Inc.于2018年6月29日在特拉华州注册成立。该公司是一家后期临床细胞治疗公司，正在为癌症患者推进专有的下一代自体嵌合抗原受体（CAR）T细胞候选产品。该公司的目标是充分实现细胞疗法对血液系统恶性肿瘤和实体瘤患者的治疗潜力。为了实现这一目标，该公司正在开拓旨在产生T细胞疗法的新方法，以推动持久的临床反应。该公司的CAR T细胞候选产品从确定有前景的癌症靶点开始。然后，该公司设计患者自己的活免疫细胞，并为其提供创新的增强功能，包括CAR构建、技术和制造方案，旨在赋予T细胞更强大的癌症细胞杀伤能力。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.135683},{"month":2,"riseRate":0.6,"avgChangeRate":0.14638},{"month":3,"riseRate":0.2,"avgChangeRate":-0.169677},{"month":4,"riseRate":0.2,"avgChangeRate":-0.056815},{"month":5,"riseRate":0.4,"avgChangeRate":0.090457},{"month":6,"riseRate":0.4,"avgChangeRate":-0.020193},{"month":7,"riseRate":0.4,"avgChangeRate":0.020455},{"month":8,"riseRate":0.4,"avgChangeRate":-0.008473},{"month":9,"riseRate":0.4,"avgChangeRate":0.012765},{"month":10,"riseRate":0.4,"avgChangeRate":-0.081669},{"month":11,"riseRate":0.4,"avgChangeRate":-0.025774},{"month":12,"riseRate":0.4,"avgChangeRate":-0.056847}],"exchange":"NASDAQ","name":"Lyell Immunopharma, Inc.","nameEN":"Lyell Immunopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lyell Immunopharma, Inc.(LYEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lyell Immunopharma, Inc.(LYEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lyell Immunopharma, Inc.,LYEL,Lyell Immunopharma, Inc.股票,Lyell Immunopharma, Inc.股票老虎,Lyell Immunopharma, Inc.股票老虎国际,Lyell Immunopharma, Inc.行情,Lyell Immunopharma, Inc.股票行情,Lyell Immunopharma, Inc.股价,Lyell Immunopharma, Inc.股市,Lyell Immunopharma, Inc.股票价格,Lyell Immunopharma, Inc.股票交易,Lyell Immunopharma, Inc.股票购买,Lyell Immunopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lyell Immunopharma, Inc.(LYEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lyell Immunopharma, Inc.(LYEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}